Home › Bronchiolitis Obliterans Syndrome › New Jersey
Bronchiolitis Obliterans Syndrome clinical trials in New Jersey
4 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute of Nj, New Brunswick
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT06585774Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 2, 2026 · NCT07354074Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05919511Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
- Hackensack Meridian, Neptune City
Recruiting
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT06464926From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.